TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 234 filers reported holding TG THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $474 | -80.9% | 56,660 | -43.3% | 0.02% | -79.6% |
| Q2 2023 | $2,482 | +351.3% | 99,931 | +173.2% | 0.11% | +315.4% |
| Q1 2023 | $550 | -75.1% | 36,580 | -80.4% | 0.03% | -78.9% |
| Q4 2022 | $2,213 | -99.7% | 187,029 | +72.7% | 0.12% | +215.4% |
| Q3 2022 | $641,000 | +51.2% | 108,309 | +8.7% | 0.04% | +21.9% |
| Q2 2022 | $424,000 | -33.2% | 99,670 | +716.4% | 0.03% | -82.3% |
| Q4 2020 | $635,000 | – | 12,208 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 2,813,779 | $33,568,000 | 3.32% |
| Opaleye Management Inc. | 300,000 | $3,579,000 | 1.50% |
| BRIDGER MANAGEMENT, LLC | 3,068,315 | $36,605,000 | 1.21% |
| SECTORAL ASSET MANAGEMENT INC | 1,521,667 | $18,153,000 | 0.77% |
| STONERIDGE INVESTMENT PARTNERS LLC | 332,576 | $3,968,000 | 0.53% |
| Eventide Asset Management | 537,600 | $6,414,000 | 0.32% |
| Baker Brothers Advisors | 2,003,991 | $23,908,000 | 0.20% |
| Quantitative Systematic Strategies LLC | 25,270 | $302,000 | 0.08% |
| Candriam S.C.A. | 236,200 | $2,818,000 | 0.08% |
| COLUMBUS CIRCLE INVESTORS | 705,389 | $8,415,000 | 0.07% |